Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Antithrombotic Drug Use in Patients With Ischemic Stroke and Microbleeds

NCT05032053 is registered in ClinicalTrials.gov with Xijing Hospital as lead sponsor.

NCT NCT05032053
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05032053 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Antithrombotic Drug Use in Patients With Ischemic Stroke and Microbleeds
Lead sponsor
Xijing Hospital
Phase
Observational
Overall status
Recruiting
Start date
March 1, 2022
Completion date
December 1, 2027
Enrollment
3,000 (estimated)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

ischemic stroke